ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Neurology Prescribers in Mississippi

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT HERNDON M.D.

Neurology

2,615

$1.42M

185
44 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$542
Average prescription price

Avg: $145

CHELSEA GROW DO

Neurology

5,202

$912K

433
216 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$175
Average prescription price

Avg: $145

ANGELA CHANDLER M.D.

Neurology

2,111

$836K

214
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$396
Average prescription price

Avg: $145

LEE VOULTERS MD

Neurology

4,431

$823K

442
231 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$186
Average prescription price

Avg: $145

ABHA MISHRA MD

Neurology

3,574

$790K

462
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$221
Average prescription price

Avg: $145

JAMES PARKER M.D.

Neurology

3,328

$760K

359
241 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$228
Average prescription price

Avg: $145

WENDELL HELVESTON MD

Neurology

4,443

$700K

381
210 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$158
Average prescription price

Avg: $145

RONALD SCHWARTZ MD

Neurology

5,216

$660K

536
451 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 24%

$127
Average prescription price

Avg: $145

ANDREW KERBY M.D.

Neurology

5,421

$620K

411
210 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $145

KATHLEEN MESSENGER M.D.

Neurology

2,921

$614K

283
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$210
Average prescription price

Avg: $145

AAMIR HASHMAT M.D.

Neurology

4,910

$608K

627
452 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 10%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$124
Average prescription price

Avg: $145

LENNON BOWEN M.D.

Neurology

2,303

$567K

242
169 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$246
Average prescription price

Avg: $145

AREMMIA TANIOUS M.D.

Neurology

10,444

$558K

810
483 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

37%
patients receiving schedule three controlled substances

Avg: 10%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $145

RAFIQUE AHMAD M.D.

Neurology

4,232

$547K

546
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$129
Average prescription price

Avg: $145

MOHAMAD HADIDI M.D.

Neurology

5,338

$532K

472
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$100
Average prescription price

Avg: $145

DEBASHIS BISWAS M.D.

Neurology

3,869

$510K

518
344 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$132
Average prescription price

Avg: $145

CHRISTOPHER LYNN MD

Neurology

3,854

$498K

381
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 24%

$129
Average prescription price

Avg: $145

JOSEPH FARINA M.D.

Neurology

5,020

$479K

297
123 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

45%
patients receiving schedule three controlled substances

Avg: 10%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 24%

$96
Average prescription price

Avg: $145

DIANE ROSS M.D.

Neurology

2,099

$472K

189
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$225
Average prescription price

Avg: $145

WILLIAM EVANS MD

Neurology

2,966

$424K

296
192 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $145

WILLIAM OWENS M.D.

Neurology

4,221

$412K

395
193 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$98
Average prescription price

Avg: $145

MALCOLM ROLAND M.D.

Neurology

2,302

$410K

242
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$178
Average prescription price

Avg: $145

PATRICK WELDON M.D.

Neurology

2,860

$402K

290
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 24%

$140
Average prescription price

Avg: $145

MECHERI SUNDARAM M.D.

Neurology

2,898

$399K

211
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$138
Average prescription price

Avg: $145

MICHAEL MITCHELL MD

Neurology

2,634

$377K

261
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 10%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $145

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank